Aptose Biosciences Inc. (APTO) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 63 transactions totaling $3.9M, demonstrating a bearish sentiment with -$1.9M in net insider flow. The most recent transaction on Sep 22, 2023 involved a purchase of 17,000 shares valued at $53.4K.
No significant insider buying has been recorded for APTO in the recent period.
No significant insider selling has been recorded for APTO in the recent period.
Based on recent SEC filings, insider sentiment for APTO is bearish with an Insider Alignment Score of 25/100 and a net flow of -$1.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Aptose Biosciences Inc. (APTO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading APTO stock, having executed 63 transactions in the past 90 days. The most active insider is William G. Rice (Executive), who has made 14 transactions totaling $1.2M.
Get notified when executives and directors at APTO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 22, 2023 | R. Seizinger Bernd | Executive | Purchase | 17,000 | $3.14 | $53.4K | |
| Jan 19, 2023 | Bejar Rafael | Executive | Award | 100,000 | $N/A | $0 | |
| Jan 19, 2023 | Ledru Philippe | Executive | Award | 100,000 | $N/A | $0 | |
| Jan 19, 2023 | Payne Fletcher | Executive | Award | 100,000 | $N/A | $0 | |
| Jan 19, 2023 | G. Rice William | Executive | Award | 150,000 | $N/A | $0 | |
| Sep 19, 2022 | Payne Fletcher | Executive | Purchase | 10,000 | $0.68 | $6.8K | |
| Sep 19, 2022 | G. Rice William | Executive | Purchase | 10,000 | $0.68 | $6.8K | |
| Jun 6, 2022 | G. Rice William | Executive | Purchase | 10,000 | $0.97 | $9.7K | |
| Dec 20, 2021 | R. Burger Denis | Executive | Purchase | 10,000 | $1.45 | $14.5K | |
| Dec 16, 2021 | G. Rice William | Executive | Purchase | 13,183 | $1.52 | $20.0K | |
| Dec 16, 2021 | Platzer Erich | Executive | Purchase | 30,000 | $1.38 | $41.4K | |
| Dec 16, 2021 | Platzer Erich | Executive | Purchase | 50,000 | $1.37 | $68.5K | |
| Dec 16, 2021 | Platzer Erich | Executive | Purchase | 20,000 | $1.40 | $28.0K | |
| Dec 15, 2021 | G. Rice William | Executive | Purchase | 17,822 | $1.12 | $20.0K | |
| Dec 15, 2021 | Platzer Erich | Executive | Purchase | 30,000 | $1.19 | $35.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 15 | $2.9M | 73.1% |
Purchase(P) | 27 | $963.6K | 24.2% |
Exercise(M) | 9 | $105.3K | 2.6% |
Award(A) | 12 | $0 | 0.0% |
Insider selling pressure at Aptose Biosciences Inc. has increased, with 11 insiders executing 63 transactions across all time. Total sales of $2.9M significantly outpace purchases of $963.6K, resulting in a net outflow of $1.9M. This selling activity appears largely discretionary, which may warrant closer attention from investors.